SeaCrest Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,400	Closed	-$258K	–	697
2024 Q4	$258K	Sell	6,400 -790	-11%	-$31.8K	0.03%	537
2024 Q3	$455K	Buy	7,190 +581	+9%	+$36.8K	0.05%	367
2024 Q2	$350K	Sell	6,609 -1,800	-21%	-$95.4K	0.04%	414
2024 Q1	$690K	Buy	+8,409	New	+$690K	0.08%	248